GAINPEP

We believe that FGF-P is the best candidate to date for mitigation of GI syndrome. We are aware that the industry has previously tried and failed to produce an FGF mimetic. Therefore, we have the first and only reliably synthesizable FGF. A body of 30 years' worth of literature on FGFs illustrates the near certain probability of this project's success... Furthermore, FGF-P has other potential uses for peacetime, as well as national emergency situations. For example, FGF-P has the potential to mitigate radiation-induced skin injuries, heal ischemic wounds, and mitigate bone marrow syndromes. Hence, we believe this first step will be important as we establish the roles FGF-P might play in case of a radiological/nuclear event... Our research focuses on the powerful wound-healing drug candidate fibroblast growth factor-peptide (FGF-P) and its derivatives. This agent will allow for many marketing opportunities, ranging from biosecurity to basic research to bone marrow transplantation to..

Also known as: GainPep, Inc.